These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 35809350)

  • 1. An evaluation of a pilot of daily testing of SARS-CoV-2 contacts in acute hospital and ambulance trusts in England.
    Bow SMA; Goddard A; Cope G; Sharp N; Schick J; Woods C; Jeffery K; Harrington D; Williams S; Rodger AJ; Finer S; Fowler T; Hopkins S; Tunkel SA
    Public Health; 2022 Aug; 209():46-51. PubMed ID: 35809350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acceptability of testing contacts of confirmed COVID-19 cases using serial, self-administered lateral flow devices as an alternative to self-isolation.
    Love NK; Ready DR; Turner C; Yardley L; Rubin GJ; Hopkins S; Oliver I
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35947525
    [No Abstract]   [Full Text] [Related]  

  • 4. Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Young BC; Eyre DW; Kendrick S; White C; Smith S; Beveridge G; Nonnenmacher T; Ichofu F; Hillier J; Oakley S; Diamond I; Rourke E; Dawe F; Day I; Davies L; Staite P; Lacey A; McCrae J; Jones F; Kelly J; Bankiewicz U; Tunkel S; Ovens R; Chapman D; Bhalla V; Marks P; Hicks N; Fowler T; Hopkins S; Yardley L; Peto TEA
    Lancet; 2021 Oct; 398(10307):1217-1229. PubMed ID: 34534517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission.
    Lee LYW; Rozmanowski S; Pang M; Charlett A; Anderson C; Hughes GJ; Barnard M; Peto L; Vipond R; Sienkiewicz A; Hopkins S; Bell J; Crook DW; Gent N; Walker AS; Peto TEA; Eyre DW
    Clin Infect Dis; 2022 Feb; 74(3):407-415. PubMed ID: 33972994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative process analysis of daily contact testing as an alternative to self-isolation following close contact with a confirmed carrier of SARS-CoV-2.
    Denford S; Martin AF; Towler L; Mowbray F; Essery R; Bloomer R; Ready D; Love N; Amlôt R; Oliver I; Rubin GJ; Yardley L
    BMC Public Health; 2022 Jul; 22(1):1373. PubMed ID: 35850742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement with daily testing instead of self-isolating in contacts of confirmed cases of SARS-CoV-2.
    Martin AF; Denford S; Love N; Ready D; Oliver I; Amlôt R; Rubin GJ; Yardley L
    BMC Public Health; 2021 Jun; 21(1):1067. PubMed ID: 34090404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of social contacts on SARS-CoV-2 exposure among healthcare workers.
    Emecen AN; Keskin S; Boncukcu Eren E; Yildirim Ustuner B; Celik SG; Suner AF; Sezgin E; Siyve N; Basoglu Sensoy E; Tutal Altas E; Demiral Y
    Occup Med (Lond); 2022 Jan; 72(1):10-16. PubMed ID: 34633044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach.
    Green K; Micocci M; Hicks T; Winter A; Martin JE; Shinkins B; Shaw L; Price C; Davies K; Allen JA
    BMJ Open; 2022 Nov; 12(11):e064038. PubMed ID: 36328389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    Lamb G; Heskin J; Randell P; Mughal N; Moore LS; Jones R; Davies GW; Rayment M
    J Infect; 2021 Oct; 83(4):452-457. PubMed ID: 34364950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologies.
    Ryan F; Cole-Hamilton J; Dandamudi N; Futschik ME; Needham A; Saquib R; Kulasegaran-Shylini R; Blandford E; Kidd M; O'Moore É; Hall I; Sudhanva M; Klapper P; Dodgson A; Moore A; Duke M; Tunkel S; Kenny C; Fowler T
    Sci Rep; 2024 Mar; 14(1):7475. PubMed ID: 38553484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020.
    Rolfes MA; Grijalva CG; Zhu Y; McLean HQ; Hanson KE; Belongia EA; Halasa NB; Kim A; Meece J; Reed C; Talbot HK; Fry AM
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1633-1637. PubMed ID: 33382676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
    Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
    Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of routine SARS-CoV-2 screening of healthcare-workers in acute care hospitals in 2020: a systematic review and meta-analysis.
    Jabs JM; Schwabe A; Wollkopf AD; Gebel B; Stadelmaier J; Erdmann S; Radicke F; Grundmann H; Kramer A; Monsef I; Rücker G; Rupp J; Scheithauer S; Schmucker C; Simon A; Mutters NT
    BMC Infect Dis; 2022 Jul; 22(1):587. PubMed ID: 35780088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?
    Menting T; Krause K; Benz-Tettey F; Boehringer R; Laufer D; Gruber B; Crump M; Schieferdecker R; Reuhl S; Kaeferstein A; Engelhart S; Streeck H; Marx B; Aldabbagh S; Eis-Hübinger A; Rockstroh JK; Schwarze-Zander C
    Int J Hyg Environ Health; 2021 Jan; 231():113653. PubMed ID: 33137564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.